Tirzepatide injection technique and storage basics
General principles for a weekly subcutaneous injection — your specific product's instructions always govern.
Subcutaneous, once weekly
Tirzepatide is injected subcutaneously (into the fat layer under the skin) once weekly, on the same day each week, at any time of day, with or without food. The branded product comes in pre-filled, single-dose pens or vials; compounded versions are typically supplied in vials with separate syringes.
Where and why to rotate
Common sites are the abdomen (avoiding the area right around the navel), the front of the thigh, or the back of the upper arm. Rotating sites week to week helps avoid skin reactions and lumps (lipohypertrophy) that can affect absorption. Clean technique reduces infection risk.
Keeping it stable
Tirzepatide is generally stored refrigerated (not frozen), with the product's labeling specifying any allowed room-temperature window and how long it remains usable outside the fridge. Protect it from light and heat. Proper cold-chain handling during shipping matters — one reason to confirm a provider's shipping practices.
Why instructions vary
Compounded tirzepatide may differ in concentration and formulation, which changes the volume you draw and potentially the storage and beyond-use dating. Never assume branded instructions apply to a compounded vial. Follow the specific directions from your prescriber and pharmacy precisely, and ask if anything is unclear.
Not advice
This is general education, not instruction for self-administration. Always follow the specific guidance for your exact product and your clinician's directions. Compounded tirzepatide is not FDA-approved.
What to verify for your specific product
Because handling specifics differ between products — and especially between branded pens and compounded vials — it is worth confirming a short checklist with your pharmacy rather than assuming. Verify the exact storage temperature and how long the product remains usable if left at room temperature; the concentration and how it maps to the volume you draw for your prescribed dose; the beyond-use date for a compounded vial; whether the product should be discarded if exposed to freezing or excess heat; and how it was shipped, since cold-chain lapses can affect stability. For compounded preparations, ask whether the pharmacy provides a certificate of analysis and clear, written administration instructions. None of this is meant to enable self-prescribing — it is the kind of practical confirmation that prevents dosing errors and spoiled product. When anything is unclear, ask before injecting rather than guessing. Following the precise instructions for your exact preparation is the single most reliable way to keep a weekly injection both safe and effective, particularly when concentrations vary across sources.
Primary sources
- U.S. Food and Drug Administration. Mounjaro and Zepbound (tirzepatide) prescribing information. Eli Lilly and Company.
- Urva S, Quinlan T, Landry J, et al. The novel dual GIP/GLP-1 receptor agonist tirzepatide: pharmacokinetics in healthy participants. Clin Pharmacokinet. 2022.
Citations are provided for educational reference. This article summarizes published research in plain language and is not medical advice. Always consult a licensed clinician.
Common questions
Where do you inject tirzepatide?
Subcutaneously into the abdomen, front of the thigh, or back of the upper arm, rotating sites weekly. Follow your product's specific instructions.
How is tirzepatide stored?
Generally refrigerated and protected from light, with a product-specific room-temperature allowance. Compounded products may differ — follow your pharmacy's directions.
Does compounded tirzepatide use the same dose volume?
Not necessarily — compounded products can have different concentrations, changing the volume drawn. Follow the exact instructions provided.